KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Acadia Pharmaceuticals (ACAD) Shares Outstanding (2016 - 2024)

Historic Shares Outstanding for Acadia Pharmaceuticals (ACAD) over the last 16 years, with Q4 2024 value amounting to $166.7 million.

  • Acadia Pharmaceuticals' Shares Outstanding rose 125.03% to $166.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $166.7 million, marking a year-over-year increase of 125.03%. This contributed to the annual value of $166.7 million for FY2024, which is 125.03% up from last year.
  • As of Q4 2024, Acadia Pharmaceuticals' Shares Outstanding stood at $166.7 million, which was up 125.03% from $164.7 million recorded in Q4 2023.
  • Acadia Pharmaceuticals' Shares Outstanding's 5-year high stood at $166.7 million during Q4 2024, with a 5-year trough of $159.6 million in Q4 2020.
  • Its 5-year average for Shares Outstanding is $162.8 million, with a median of $162.1 million in 2022.
  • As far as peak fluctuations go, Acadia Pharmaceuticals' Shares Outstanding soared by 280.95% in 2020, and later skyrocketed by 65.35% in 2022.
  • Over the past 5 years, Acadia Pharmaceuticals' Shares Outstanding (Quarter) stood at $159.6 million in 2020, then rose by 0.86% to $161.0 million in 2021, then grew by 0.65% to $162.1 million in 2022, then rose by 1.6% to $164.7 million in 2023, then increased by 1.25% to $166.7 million in 2024.
  • Its last three reported values are $166.7 million in Q4 2024, $164.7 million for Q4 2023, and $162.1 million during Q4 2022.